查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1619787

2024年全球核酸增幅檢查市場報告

Nucleic Acid Amplification Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

核酸增幅檢查（NAAT）市場規模預計將在未來幾年快速成長。 2028年，將以15.1%的複合年成長率成長至167.7億美元。預測期內的成長將由感染疾病率上升、對大規模檢測能力的需求、私營部門投資的增加、對快速和準確檢測方法的需求不斷成長以及對先進診斷工具的需求不斷成長所推動。主要趨勢包括人工智慧 (AI) 的整合、穿戴式和植入設備的進步、就地檢驗的使用增加、個人化醫療的成長以及與數位健康技術的整合。

感染疾病率的上升預計將推動核酸增幅檢查市場的未來成長。感染疾病是由生物體引起的疾病，可以透過多種方式在人與人之間直接或間接傳播，包括身體接觸、空氣傳播、受污染的食品或水以及昆蟲感染。感染疾病的增加受到抗生素抗藥性、氣候變遷、人類行為變化和農業實踐變化等因素的影響。核酸增幅檢查可以快速且準確地檢測傳染源，從而實現快速診斷和治療。例如，2023 年 10 月，加拿大政府機構公共衛生局報告稱，參與省份和地區在 2022-2023 年季節期間記錄了 4,216 例與流感相關的住院病例。因此，感染疾病發病率的增加促進了 NAAT 市場的成長。

核酸增幅檢查市場的主要參與企業是體外診斷 (IVD) 檢測，根據體外診斷法規 (IVDR)，使用核酸擴增技術 (NAT)篩檢捐血血液中的巨細胞病毒(CMV)。體外診斷 (IVD) 是在實驗室中對生物樣本進行的測試，以檢測體外的疾病、狀況或感染疾病。例如，2024 年 6 月，德國 GFE 發布了 PoET CMV。 PoET CMV 是一種體外診斷工具，旨在快速、準確地檢測 CMV 感染。它具有高靈敏度和特異性，可以對移植受者和免疫力缺乏患者的 CMV 進行早期診斷和有效監測。該檢測採用先進的分子技術，可快速提供可靠的結果並幫助及時做出臨床決策。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球核酸增幅檢查市場推動與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023年全球核酸增幅檢查市場規模表現及成長
  • 2023-2028、2033年全球核酸增幅檢查市場規模及成長預測

第6章 市場細分

  • 全球核酸增幅檢查市場：按類型、性能和預測，2018-2023、2023-2028、2033
  • 目標放大系統
  • 探針放大系統
  • 訊號放大系統
  • 全球核酸增幅檢查市場：產品種類、效能及預測，2018-2023、2023-2028、2033
  • 消耗品
  • 設備或系統
  • 全球核酸增幅檢查市場：依技術、效能和預測分類，2018-2023、2023-2028、2033
  • 聚合酵素鏈鎖反應（PCR）測試
  • 恒溫核酸增幅技術（INAAT）測試
  • 連接酶鏈反應（LCR）測試
  • 全球核酸增幅檢查市場：依應用、效能和預測分類，2018-2023、2023-2028、2033
  • 傳染病檢查
  • 腫瘤檢查
  • 遺傳和粒線體疾病檢測
  • 其他
  • 全球核酸增幅檢查市場：依最終用途、性能和預測，2018-2023、2023-2028、2033
  • 醫院
  • 診斷實驗室
  • 生技公司
  • 其他

第 7 章 區域/國家分析

  • 全球核酸增幅檢查市場，依地區、績效及預測，2018-2023、2023-2028、2033
  • 全球核酸增幅檢查市場，依國家、績效及預測，2018-2023年、2023-2028年、2033年

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 核酸增幅檢查市場競爭格局
  • 核酸增幅檢查市場企業概況
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Merck KGaA
    • Siemens Healthineers

第31章 其他大型創新企業

  • Becton, Dickinson and Company
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics
  • Agilent Technologies Inc.
  • Grifols SA
  • Hologic Inc.
  • bioMerieux SA
  • QuidelOrtho Corporation
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • GenScript BIoTech Corporation
  • ARUP Laboratories
  • BGI Group
  • Promega Corporation
  • Meridian Bioscience Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r20774

Nucleic acid amplification testing (NAAT) encompasses molecular techniques designed to detect and amplify specific deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) within a sample. It is widely employed to identify pathogens at early stages of infection due to its high sensitivity. Researchers utilize NAAT to investigate gene expression, genetic variations, and disease mechanisms, which aids in understanding the bases of genetic diseases and developing targeted therapies.

The primary types of nucleic acid amplification testing include target amplification systems, probe amplification systems, and signal amplification systems. Target amplification systems are methods used to amplify specific nucleic acid sequences in a sample, crucial for improving the sensitivity and accuracy of NAAT. Product types in this field include consumables and instruments or systems featuring various technologies, such as polymerase chain reaction (PCR) tests, isothermal nucleic acid amplification technology (INAAT) tests, and ligase chain reaction (LCR) tests. NAAT is utilized in numerous applications, including infectious disease testing, oncology testing, genetic and mitochondrial disease testing, among others, and is employed by various end-users such as hospitals, diagnostic laboratories, biotechnology companies, and others.

The nucleic acid amplification testing market research report is one of a series of new reports from The Business Research Company that provides nucleic acid amplification testing market statistics, including nucleic acid amplification testing industry global market size, regional shares, competitors with a nucleic acid amplification testing market share, detailed nucleic acid amplification testing market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid amplification testing industry. This nucleic acid amplification testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nucleic acid amplification testing market size has grown rapidly in recent years. It will grow from $8.33 billion in 2023 to $9.56 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth during the historic period can be attributed to increased awareness of infectious disease diagnosis, the emergence of new pathogens, a shift towards personalized medicine, rising demand for point-of-care testing, and supportive regulatory approvals and guidelines.

The nucleic acid amplification testing market size is expected to see rapid growth in the next few years. It will grow to $16.77 billion in 2028 at a compound annual growth rate (CAGR) of 15.1%. The growth during the forecast period can be attributed to the rising incidence of infectious diseases, the need for large-scale testing capabilities, increasing private sector investments, a growing demand for rapid and accurate testing methods, and a heightened need for advanced diagnostic measures. Major trends include the integration of artificial intelligence (AI), advancements in wearable and implantable devices, expanding use in point-of-care testing, growth in personalized medicine, and integration with digital health technologies.

The rising incidence of infectious diseases is expected to drive the growth of the nucleic acid amplification testing (NAAT) market in the future. Infectious diseases are conditions caused by organisms that can spread directly or indirectly from one individual to another through various means, such as physical contact, airborne transmission, contaminated food or water, or insect-borne transmission. The rise in infectious diseases is influenced by factors like antibiotic resistance, climate change, shifts in human behavior, and changes in agricultural practices. Nucleic acid amplification testing (NAAT) quickly and accurately detects infectious pathogens, enabling prompt diagnosis and treatment, which helps in controlling the spread of diseases. For example, in October 2023, the Public Health Agency of Canada, a government agency, reported that during the 2022-2023 season, participating provinces and territories documented 4,216 hospitalizations related to influenza. As a result, the increasing incidence of infectious diseases is contributing to the growth of the NAAT market.

Key players in the nucleic acid amplification testing (NAAT) market are focusing on developing innovative solutions, such as in vitro diagnostics (IVD) assays, to screen donated blood for cytomegalovirus (CMV) using nucleic acid amplification technology (NAT) in accordance with the In Vitro Diagnostic Regulation (IVDR). An IVD assay is a test conducted on biological samples in a laboratory to detect diseases, conditions, or infections outside the body. For example, in June 2024, GFE, a Germany-based company, introduced the PoET CMV. PoET CMV is an IVD assay designed for the rapid and accurate detection of CMV infections. Its standout features include high sensitivity and specificity, enabling early diagnosis and effective monitoring of CMV in transplant recipients and immunocompromised individuals. The assay employs advanced molecular techniques to provide reliable results quickly, aiding in timely clinical decision-making.

In July 2024, Roche Holding AG acquired LumiraDx for an undisclosed amount. This acquisition allows Roche to expand its diagnostics portfolio and offer a wider range of immunoassay and clinical chemistry tests. LumiraDx, a UK-based provider of nucleic acid amplification testing, will enhance Roche's capabilities in providing thorough, high-value testing without the need for specialized cold storage. This makes it suitable for diverse healthcare settings and improves testing efficiency and patient outcomes, especially in primary care and underserved areas.

Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation

North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nucleic acid amplification testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nucleic acid amplification testing (NAAT) market consists of revenue earned by entities by provide services such as genetic disorder screening, environmental testing, infectious disease diagnosis, and pharmacogenomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid amplification testing (NAAT) market also includes sales of reagents, pre-packaged kits, test tubes, pipettes, and plates. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nucleic Acid Amplification Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nucleic acid amplification testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nucleic acid amplification testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nucleic acid amplification testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Target Amplification Systems; Probe Amplification Systems; Signal Amplification Systems
  • 2) By Product Type: Consumables; Instruments Or Systems
  • 3) By Technology: Polymerase Chain Reaction (PCR) Tests; Isothermal Nucleic Acid Amplification Technology (INAAT) Tests; Ligase Chain Reaction (LCR) Tests
  • 4) By Application: Infectious Disease Testing; Oncology Testing; Genetic And Mitochondrial Disease Testing; Other Applications
  • 5) By End-Use: Hospitals; Diagnostic Laboratories; Biotechnology Companies; Other End-Users
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Siemens Healthineers
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nucleic Acid Amplification Testing (NAAT) Market Characteristics

3. Nucleic Acid Amplification Testing (NAAT) Market Trends And Strategies

4. Nucleic Acid Amplification Testing (NAAT) Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Nucleic Acid Amplification Testing (NAAT) Market Size and Growth

  • 5.1. Global Nucleic Acid Amplification Testing (NAAT) Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Nucleic Acid Amplification Testing (NAAT) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Nucleic Acid Amplification Testing (NAAT) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Nucleic Acid Amplification Testing (NAAT) Market Segmentation

  • 6.1. Global Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Target Amplification Systems
  • Probe Amplification Systems
  • Signal Amplification Systems
  • 6.2. Global Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables
  • Instruments Or Systems
  • 6.3. Global Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Polymerase Chain Reaction (PCR) Tests
  • Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  • Ligase Chain Reaction (LCR) Tests
  • 6.4. Global Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infectious Disease Testing
  • Oncology Testing
  • Genetic And Mitochondrial Disease Testing
  • Other Applications
  • 6.5. Global Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Biotechnology Companies
  • Other End-Uses

7. Nucleic Acid Amplification Testing (NAAT) Market Regional And Country Analysis

  • 7.1. Global Nucleic Acid Amplification Testing (NAAT) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Nucleic Acid Amplification Testing (NAAT) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Nucleic Acid Amplification Testing (NAAT) Market

  • 8.1. Asia-Pacific Nucleic Acid Amplification Testing (NAAT) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Nucleic Acid Amplification Testing (NAAT) Market

  • 9.1. China Nucleic Acid Amplification Testing (NAAT) Market Overview
  • 9.2. China Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Nucleic Acid Amplification Testing (NAAT) Market

  • 10.1. India Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Nucleic Acid Amplification Testing (NAAT) Market

  • 11.1. Japan Nucleic Acid Amplification Testing (NAAT) Market Overview
  • 11.2. Japan Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Nucleic Acid Amplification Testing (NAAT) Market

  • 12.1. Australia Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Nucleic Acid Amplification Testing (NAAT) Market

  • 13.1. Indonesia Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Nucleic Acid Amplification Testing (NAAT) Market

  • 14.1. South Korea Nucleic Acid Amplification Testing (NAAT) Market Overview
  • 14.2. South Korea Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Nucleic Acid Amplification Testing (NAAT) Market

  • 15.1. Western Europe Nucleic Acid Amplification Testing (NAAT) Market Overview
  • 15.2. Western Europe Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Nucleic Acid Amplification Testing (NAAT) Market

  • 16.1. UK Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Nucleic Acid Amplification Testing (NAAT) Market

  • 17.1. Germany Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Nucleic Acid Amplification Testing (NAAT) Market

  • 18.1. France Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Nucleic Acid Amplification Testing (NAAT) Market

  • 19.1. Italy Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Nucleic Acid Amplification Testing (NAAT) Market

  • 20.1. Spain Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Nucleic Acid Amplification Testing (NAAT) Market

  • 21.1. Eastern Europe Nucleic Acid Amplification Testing (NAAT) Market Overview
  • 21.2. Eastern Europe Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Nucleic Acid Amplification Testing (NAAT) Market

  • 22.1. Russia Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Nucleic Acid Amplification Testing (NAAT) Market

  • 23.1. North America Nucleic Acid Amplification Testing (NAAT) Market Overview
  • 23.2. North America Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Nucleic Acid Amplification Testing (NAAT) Market

  • 24.1. USA Nucleic Acid Amplification Testing (NAAT) Market Overview
  • 24.2. USA Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Nucleic Acid Amplification Testing (NAAT) Market

  • 25.1. Canada Nucleic Acid Amplification Testing (NAAT) Market Overview
  • 25.2. Canada Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Nucleic Acid Amplification Testing (NAAT) Market

  • 26.1. South America Nucleic Acid Amplification Testing (NAAT) Market Overview
  • 26.2. South America Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Nucleic Acid Amplification Testing (NAAT) Market

  • 27.1. Brazil Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Nucleic Acid Amplification Testing (NAAT) Market

  • 28.1. Middle East Nucleic Acid Amplification Testing (NAAT) Market Overview
  • 28.2. Middle East Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Nucleic Acid Amplification Testing (NAAT) Market

  • 29.1. Africa Nucleic Acid Amplification Testing (NAAT) Market Overview
  • 29.2. Africa Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Nucleic Acid Amplification Testing (NAAT) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Nucleic Acid Amplification Testing (NAAT) Market Competitive Landscape And Company Profiles

  • 30.1. Nucleic Acid Amplification Testing (NAAT) Market Competitive Landscape
  • 30.2. Nucleic Acid Amplification Testing (NAAT) Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck KGaA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens Healthineers
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Nucleic Acid Amplification Testing (NAAT) Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson and Company
  • 31.2. Laboratory Corporation of America Holdings
  • 31.3. Quest Diagnostics
  • 31.4. Agilent Technologies Inc.
  • 31.5. Grifols S.A.
  • 31.6. Hologic Inc.
  • 31.7. bioMerieux SA
  • 31.8. QuidelOrtho Corporation
  • 31.9. Bio-Rad Laboratories Inc.
  • 31.10. Cepheid Inc.
  • 31.11. GenScript Biotech Corporation
  • 31.12. ARUP Laboratories
  • 31.13. BGI Group
  • 31.14. Promega Corporation
  • 31.15. Meridian Bioscience Inc.

32. Global Nucleic Acid Amplification Testing (NAAT) Market Competitive Benchmarking

33. Global Nucleic Acid Amplification Testing (NAAT) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Nucleic Acid Amplification Testing (NAAT) Market

35. Nucleic Acid Amplification Testing (NAAT) Market Future Outlook and Potential Analysis

  • 35.1 Nucleic Acid Amplification Testing (NAAT) Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Nucleic Acid Amplification Testing (NAAT) Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Nucleic Acid Amplification Testing (NAAT) Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer